Travel Vaccines Market Size, Share, Trends, Growth Outlook

Travel Vaccines Market is estimated to increase at a growth rate of 10.2% CAGR over the forecast period from 2024 to 2030.

The global Travel Vaccines Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines).

An Introduction to Travel Vaccines Market in 2024

The Travel Vaccines Market comprises travel immunizations, travel health vaccines, and travel medicine services used in pre-travel consultations, travel clinics, and international travel health advisories for preventing travel-related infections, tropical diseases, and vaccine-preventable illnesses in travelers visiting endemic regions, high-risk areas, and developing countries. Travel vaccines offer protection against diseases such as yellow fever, typhoid, hepatitis, malaria, and other infectious diseases prevalent in travel destinations, ensuring traveler safety, health security, and disease prevention during trips abroad. Market trends encompass travel vaccine recommendations, travel health guidelines, vaccine efficacy studies, and emerging travel vaccine research for global travel health management and infectious disease prevention strategies.

Travel Vaccines Market Competitive Landscape

The global Travel Vaccines Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Travel Vaccines Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Travel Vaccines Industry include- Abbott Laboratories, Altimmune Inc, AstraZeneca Plc, Bavarian Nordic AS, CSL Ltd, Dynavax Technologies Corp, Emergent BioSolutions Inc, GlaxoSmithKline Plc, KM Biologics Co. Ltd, LG Chem Ltd, Merck and Co. Inc, Novartis AG, Pfizer Inc, Sanofi SA, Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, SK Chemicals Co. Ltd, Takeda Pharmaceutical Co. Ltd, Valneva SE.

travel vaccines Market Trend: Expanding Travel Vaccine Market

The trend in the travel vaccines market is marked by its expansion driven by increasing international travel and globalization. There's a growing interest in the development and distribution of vaccines targeting infectious diseases prevalent in travel destinations. Additionally, advancements in vaccine technologies, such as the development of recombinant vaccines and novel adjuvant systems, contribute to the expansion of the travel vaccine market by enhancing vaccine efficacy, safety, and immunogenicity. The rising awareness of travel-related health risks among tourists and healthcare professionals further fuels the demand for travel vaccines, driving market growth.

travel vaccines Market Driver: Growing Emphasis on Preventive Healthcare

The primary driver for the travel vaccines market is the growing emphasis on preventive healthcare measures, especially among travelers visiting regions with endemic infectious diseases. With increasing awareness of vaccine-preventable diseases and the importance of immunization in protecting against infectious threats, there's a rising demand for travel vaccines as a proactive approach to safeguarding travelers' health. Governments, international health organizations, and travel healthcare providers advocate for vaccination as an essential component of pre-travel health planning, driving the adoption of travel vaccines and supporting market expansion.

travel vaccines Market Opportunity: Diversification of Vaccine Offerings

An opportunity exists in diversifying vaccine offerings to address emerging travel-related health threats and cater to evolving traveler needs. Companies investing in the development of vaccines targeting emerging infectious diseases, such as vector-borne illnesses, emerging respiratory viruses, and antimicrobial-resistant pathogens, can capture niche markets and differentiate their product portfolios. By leveraging advances in vaccine research, epidemiological surveillance, and regulatory pathways, stakeholders can capitalize on emerging opportunities in the travel vaccine market, offering comprehensive protection against a broader range of infectious risks and enhancing travelers' health outcomes and safety during international journeys.

Travel Vaccines Market Share Analysis: Hepatitis in Adult Vaccines is the fastest growing market segment over the forecast period to 2030

Travel vaccines for hepatitis are experiencing the most rapid growth, particularly in the adult vaccines category. Hepatitis is a viral infection that can cause inflammation of the liver and is commonly transmitted through contaminated food and water in certain regions of the world. As international travel becomes increasingly common, the demand for travel vaccines, including those for hepatitis, has surged. Hepatitis vaccines are crucial for travelers visiting areas where the prevalence of hepatitis is high, such as developing countries or regions with poor sanitation infrastructure. Additionally, hepatitis vaccines are often required or recommended by health authorities for travelers entering certain countries. The emphasis on preventive healthcare and the growing awareness of the importance of vaccination in protecting against infectious diseases have contributed to the rising demand for travel vaccines, particularly for hepatitis, among adult travelers. As individuals prioritize their health and safety during travel, the market for travel vaccines for hepatitis in the adult vaccines category is expected to continue its rapid growth, ensuring the protection of travelers from this potentially serious infection.

Travel Vaccines Market Segmentation

By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Travel Vaccines Companies

Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
* List not Exhaustive

Reasons to Buy the Travel Vaccines Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Travel Vaccines Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Travel Vaccines Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Travel Vaccines Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Travel Vaccines Market Size Outlook, $ Million, 2021 to 2030
3.2 Travel Vaccines Market Outlook by Type, $ Million, 2021 to 2030
3.3 Travel Vaccines Market Outlook by Product, $ Million, 2021 to 2030
3.4 Travel Vaccines Market Outlook by Application, $ Million, 2021 to 2030
3.5 Travel Vaccines Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Travel Vaccines Industry
4.2 Key Market Trends in Travel Vaccines Industry
4.3 Potential Opportunities in Travel Vaccines Industry
4.4 Key Challenges in Travel Vaccines Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Travel Vaccines Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Travel Vaccines Market Outlook by Segments
7.1 Travel Vaccines Market Outlook by Segments, $ Million, 2021- 2030
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
8 North America Travel Vaccines Market Analysis and Outlook To 2030
8.1 Introduction to North America Travel Vaccines Markets in 2024
8.2 North America Travel Vaccines Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Travel Vaccines Market size Outlook by Segments, 2021-2030
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
9 Europe Travel Vaccines Market Analysis and Outlook To 2030
9.1 Introduction to Europe Travel Vaccines Markets in 2024
9.2 Europe Travel Vaccines Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Travel Vaccines Market Size Outlook by Segments, 2021-2030
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
10 Asia Pacific Travel Vaccines Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Travel Vaccines Markets in 2024
10.2 Asia Pacific Travel Vaccines Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Travel Vaccines Market size Outlook by Segments, 2021-2030
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
11 South America Travel Vaccines Market Analysis and Outlook To 2030
11.1 Introduction to South America Travel Vaccines Markets in 2024
11.2 South America Travel Vaccines Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Travel Vaccines Market size Outlook by Segments, 2021-2030
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
12 Middle East and Africa Travel Vaccines Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Travel Vaccines Markets in 2024
12.2 Middle East and Africa Travel Vaccines Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Travel Vaccines Market size Outlook by Segments, 2021-2030
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines